Health Care Reform

Is drug research biased?

Critics of the pharmaceutical industry maintain that the majority of clinical trials on prescription drugs are unreliable because they are run by the very companies producing those drugs. Industry defenders say that's not the case. The two groups also disagree on whether the government should play a greater role in comparing the effectiveness of prescription drugs.

Guests

• John Abramson, MD: Clinical Instructor at Harvard Medical School and author of "Overdosed America."
• Peter Pitts: President of the Center for Medicine in the Public Interest. He was associate commissioner at the Food and Drug Administration.

Resources

• Dr. Abramson's Web site
• About Peter Pitts